B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund held its position in Thermo Fisher Scientific Inc (NYSE:TMO) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,527 shares of the medical research company’s stock at the end of the 2nd quarter. B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund’s holdings in Thermo Fisher Scientific were worth $2,883,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Waldron LP boosted its position in Thermo Fisher Scientific by 48.1% during the 1st quarter. Waldron LP now owns 4,455 shares of the medical research company’s stock valued at $661,000 after acquiring an additional 1,447 shares in the last quarter. Empire Life Investments Inc. increased its holdings in shares of Thermo Fisher Scientific by 132.0% in the 1st quarter. Empire Life Investments Inc. now owns 52,504 shares of the medical research company’s stock valued at $7,861,000 after acquiring an additional 29,875 shares during the period. Canandaigua National Bank & Trust Co. purchased a new position in shares of Thermo Fisher Scientific in the 1st quarter valued at $404,000. Bbva Compass Bancshares Inc. increased its holdings in shares of Thermo Fisher Scientific by 5.1% in the 1st quarter. Bbva Compass Bancshares Inc. now owns 25,170 shares of the medical research company’s stock valued at $3,866,000 after acquiring an additional 1,222 shares during the period. Finally, DekaBank Deutsche Girozentrale increased its holdings in shares of Thermo Fisher Scientific by 4.8% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 285,289 shares of the medical research company’s stock valued at $44,047,000 after acquiring an additional 13,080 shares during the period. 83.36% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/10/03/thermo-fisher-scientific-inc-tmo-holdings-held-by-b-s-pension-fund-trustee-ltd-acting-for-the-british-steel-pension-fund.html.

Thermo Fisher Scientific Inc (NYSE TMO) opened at 191.54 on Tuesday. The firm’s 50-day moving average is $184.55 and its 200-day moving average is $173.10. The firm has a market cap of $74.72 billion, a price-to-earnings ratio of 33.37 and a beta of 1.05. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The business had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter in the prior year, the business posted $2.03 EPS. The business’s revenue for the quarter was up 10.2% on a year-over-year basis. On average, equities analysts anticipate that Thermo Fisher Scientific Inc will post $9.34 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. Thermo Fisher Scientific’s payout ratio is currently 10.45%.

In related news, Director C Martin Harris sold 360 shares of the company’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the sale, the director now directly owns 5,312 shares of the company’s stock, valued at approximately $961,312.64. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Jim P. Manzi sold 1,000 shares of the company’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the completion of the sale, the director now directly owns 38,757 shares of the company’s stock, valued at $6,790,226.40. The disclosure for this sale can be found here. Insiders have sold a total of 52,738 shares of company stock valued at $9,302,112 in the last 90 days. Insiders own 0.49% of the company’s stock.

Several research analysts have recently commented on TMO shares. Deutsche Bank AG set a $200.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Saturday, June 10th. BidaskClub downgraded Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 27th. Citigroup Inc. reaffirmed a “buy” rating and set a $201.00 price objective (up previously from $182.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 10th. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 target price on the stock in a research note on Tuesday, July 11th. Finally, Wells Fargo & Company reiterated an “outperform” rating and issued a $200.00 target price (up previously from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Thermo Fisher Scientific has a consensus rating of “Buy” and a consensus price target of $202.21.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.